Evidence map›Paper›PMID 37357819›Full record

ArticleChembiochem : a European journal of chemical biology2023

Biosynthesis and Genome Mining Potentials of Nucleoside Natural Products.

Yanan Du, Anyarat Thanapipatsiri, Kenichi Yokoyama

Abstract read
In one paragraph

Article in Chembiochem : a European journal of chemical biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yanan DuDepartment of Biochemistry, Duke University School of Medicine, 307 Research Drive, Durham, NC 27710, USA.
Anyarat ThanapipatsiriDepartment of Biochemistry, Duke University School of Medicine, 307 Research Drive, Durham, NC 27710, USA.
Kenichi YokoyamaDepartment of Biochemistry, Duke University School of Medicine, 307 Research Drive, Durham, NC 27710, USA.ORCID 0000-0001-5625-469X

Funding

Biosynthesis of peptidyl nucleoside antifungal antibioticsR01GM115729 · NIGMS · DUKE UNIVERSITY · PI YOKOYAMA, KENICHI · 2015 to 2023
$3.1M
NIGMS NIH HHS R01 GM115729
6 · The paper itself

Abstract

Nucleoside natural products show diverse biological activities and serve as leads for various application purposes, including human and veterinary medicine and agriculture. Studies in the past decade revealed that these nucleosides are biosynthesized through divergent mechanisms, in which early steps of the pathways can be classified into two types (C5' oxidation and C5' radical extension), while the structural diversity is created by downstream tailoring enzymes. Based on this biosynthetic logic, we investigated the genome mining discovery potentials of these nucleosides using the two enzymes representing the two types of C5' modifications: LipL-type α-ketoglutarate (α-KG) and Fe-dependent oxygenases and NikJ-type radical S-adenosyl-L-methionine (SAM) enzymes. The results suggest that this approach allows discovery of putative nucleoside biosynthetic gene clusters (BGCs) and the prediction of the core nucleoside structures. The results also revealed the distribution of these pathways in nature and implied the possibility of future genome mining discovery of novel nucleoside natural products.

Indexed as

Biological ProductsNucleosidesBiosynthetic PathwaysHumansOxidation-ReductionBiological ProductsNucleosidesantibioticsantifungal agentsbiosynthesisnatural productsnucleosides

Identifiers

PMID37357819
PMCPMC10530009

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.